Fluvoxamine is used to treat obsessive-compulsive disorder (OCD). It helps decrease thoughts that are unwanted or that don’t go away (obsessions), and it helps to reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, checking) that interfere with daily living.

Certificate of Analysis

TestSpecificationResults
DescriptionWhite to off- white crystalline powder.White crystalline powder.
 

Solubility

 

Freely soluble in ethanol (95%) and methanol. Sparingly soluble in water.Complies
Identification
By IRThe Infrared spectrum of the sample should be corresponded with that of IR spectrum of the Working standard.Complies
Related substances
Impurity BNot more than 0.5 %Not Detected
Impurity CNot more than 0.3 %Not Detected
Impurity ANot more than 0.2 %Not Detected
Impurity DNot more than 0.15 %Not Detected
Impurity F & GNot more than 0.3 %0.05 %
Unspecified ImpurityNot more than 0.1 %0.04 %
Total impuritiesNot more than 1.0 %0.23 %
Loss on dryingNot more than 0.5 %0.3 %
Heavy metalNot more than 20 ppmComplies
Sulfated ashNMT 0.1 %0.04 %
Assay

By potentiometry

Not less than 99.0 % and not more than 101.0% (Dried Substance).100.2 %

Material Safety Data Sheet

SECTION 1 – CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

 

MSDS Identification Name          : Fluvoxamine Maleate  

 

Supplier                            :  ATILUS PHARMA PVT. LTD.

 

SECTION 2 – COMPOSITION, INFORMATION ON INGREDIENTS

 

CAS #Chemical Name%EINECS #
61718-82-9(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O- (2-aminoethyl)oxime maleate<=100-s

 

Synonyms                      :  (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O- (2-aminoethyl)oxime maleate

Formula                         :  C15H21F3N2O2 · C4H4O4

Molecular weight            :  434.41 g/mol

 

SECTION 3 – HAZARDS IDENTIFICATION

3.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008

Acute toxicity, Oral (Category 4), H302

For the full text of the H-Statements mentioned in this Section, see Section 16.

3.2 Label elements

Labelling according Regulation (EC) No 1272/2008

Pictogram

 

Signal word Warning

 

Hazard statement(s)

Hazard statement(s) H302            Harmful if swallowed.

Hazard statement(s)

H302 Harmful if swallowed.

Precautionary statement(s)

P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. Supplemental Hazard Statements none

3.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

 

SECTION 4 – FIRST AID MEASURES

4.1 Description of first-aid measures

General advice

Consult a physician. Show this material safety data sheet to the doctor in attendance.

After inhalation:

If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.

In case of skin contact

Wash off with soap and plenty of water. Consult a physician.

If swallowed

After swallowing: immediately make victim drink water (two glasses at most). Consult a physician.

In case of eye contact

Flush eyes with water as a precaution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section

2.2) and/or in section 11

4.3 Indication of any immediate medical attention and special treatment needed

No data available

 

SECTION 5 – FIRE FIGHTING MEASURES

5.1  Extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

5.2  Special hazards arising from the substance or mixture Carbon oxides Nitrogen oxides Carbon oxides Nitrogen oxides (NOx) Hydrogen fluoride

5.3  Advice for firefighters

Wear self-contained breathing apparatus for firefighting if necessary.

5.4  Further information

No data available

 

SECTION 6 – ACCIDENTAL RELEASE MEASURES

6.1  Personal precautions, protective equipment and emergency procedures Advice for non-emergency personnel: Avoid inhalation of dusts. Avoid substance contact. Ensure adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an expert. For personal protection see section 8.

6.2  Environmental precautions

Do not let product enter drains.

6.3  Methods and materials for containment and cleaning up

Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.

6.4  Reference to other sections

For disposal see section 13.

 

SECTION 7 – HANDLING AND STORAGE

7.1 Precautions for safe handling

Advice on safe handling

Avoid contact with skin and eyes. Avoid formation of dust and aerosols.

Advice on protection against fire and explosion

Provide appropriate exhaust ventilation at places where dust is formed.

Hygiene measures

Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. For precautions see section 2.2.

7.2 Conditions for safe storage, including any incompatibilities

Storage conditions

Keep container tightly closed in a dry and well-ventilated place. Store in cool place.

Storage stability Recommended storage temperature 2 – 8 °C

Storage class

Storage class (TRGS 510): 13: Non Combustible Solids 7.3 Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8 – EXPOSURE CONTROLS, PERSONAL PROTECTION

8.1 Control parameters

Ingredients with workplace control parameters

8.2 Exposure controls

Eye/face protection

Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).

Skin protection

Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove’s outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of Regulation (EU) 2016/425 and the standard EN 374 derived from it. Full contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) Splash contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method: EN374 If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the supplier of the EC approved gloves. This recommendation is advisory only and must be evaluated by an industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It should not be construed as offering an approval for any specific use scenario.

Body Protection

Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.

Respiratory protection

For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Control of environmental exposure

Do not let product enter drains.

 

SECTION 9 – PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

 

  1. a) Appearance Form : Solid
  2. b) Odor                  : Not applicable
  3. c) Odor                   : Not applicable
  4. d) pH : No data available
  5. e) Melting point/freezing point Melting point/range: No data available
  6. f) Autoignition :No data available

temperature

  1. g) Decomposition temperature :No data available
  2. h) Viscosity Viscosity, kinematic : No data available

Viscosity, dynamic                      : No data available

  1. i) Explosive properties : No data available
  2. j) Oxidizing properties :No data available

 

9.2 Other safety information

No data available

 

SECTION 10 – STABILITY AND REACTIVITY

10.1 Reactivity

The following applies in general to flammable organic substances and mixtures: in correspondingly fine distribution, when whirled up a dust explosion potential may generally be assumed..

10.2 Chemical stability

The following applies in general to flammable organic substances and mixtures: in correspondingly fine distribution, when whirled up a dust explosion potential may generally be assumed.

10.3 Possibility of hazardous reactions

Violent reactions possible with:

Strong oxidizing agents

10.4 Conditions to avoid

no information available

10.5 Incompatible materials

No data available

10.6 Hazardous decomposition products

In the event of fire: see section 5

 

SECTION 11 – TOXICOLOGICAL INFORMATION

11.1  Information on toxicological effects

Acute toxicity

LD50 Oral – Mouse – 1.100 mg/kg Remarks: Sense Organs and Special Senses (Nose, Eye, Ear, and Taste):Eye:Mydriasis (pupilliary dilation). Behavioral:Convulsions or effect on seizure threshold. Behavioral:Ataxia.

Inhalation: No data available

Dermal: No data available

Skin corrosion/irritation

Remarks: No data available

Serious eye damage/eye irritation

Remarks: No data available

Respiratory or skin sensitization

No data available

Germ cell mutagenicity No data available

Carcinogenicity No data available

Reproductive toxicity

No data available

Specific target organ toxicity – single exposure

No data available

 Specific target organ toxicity – repeated exposure

No data available

Aspiration hazard

No data available

11.2 Additional Information

RTECS: SA9230000 Nausea, Dizziness, Headache To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.

 

SECTION 12 – ECOLOGICAL INFORMATION

SECTION 12: Ecological information

12.1 Toxicity

No data available

12.2 Persistence and degradability

No data available

12.3 Bioaccumulative potential

No data available

12.4 Mobility in soil

No data available

12.5 Results of PBT and vPvB assessment

This substance/mixture contains no components considered to be either persistent,

bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at

levels of 0.1% or higher.

12.6 Other adverse effects

No data available

 

SECTION 13 – DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Product Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Waste material must be disposed of in accordance with the Directive on waste 2008/98/EC as well as other national and local regulations. Leave chemicals in original containers. No mixing with other waste. Handle uncleaned containers like the product itself

Contaminated packaging

Dispose of as unused product.

 

SECTION 14 – TRANSPORT INFORMATION

 

14.1 UN number

ADR/RID:  –  IMDG:  –  IATA:  –

14.2 UN proper shipping name

ADR/RID:  Not dangerous goods

IMDG:  Not dangerous goods

IATA:  Not dangerous goods

14.3 Transport hazard class(es)

ADR/RID:  –  IMDG:  –  IATA:  –

14.4 Packaging group

ADR/RID:  –  IMDG:  –  IATA:  –

14.5 Environmental hazards

ADR/RID:  no IMDG Marine pollutant: no IATA: no

14.6 Special precautions for user

Further information

Not classified as dangerous in the meaning of transport regulations.

 

 

 

SECTION 15 – REGULATORY INFORMATION

15.1 Safety, health and environmental regulations/legislation specific for the

substance or mixture

This material safety data sheet complies with the requirements of Regulation (EC) No.

1907/2006.

National legislation

Seveso III: Directive 2012/18/EU of the

European Parliament and of the Council on the

control of major-accident hazards involving

dangerous substances.                                :Not applicable

 

SECTION 16 – ADDITIONAL INFORMATION

The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

WhatsApp
+91 9819994077
India Copyrights © 2024 Atilus Pharma All right reserved.
Primetech Nxt
Developed By Primetech NXT